Skip to main content
. 2012 Aug 30;2012:492578. doi: 10.5402/2012/492578

Table 2.

Clinical features and pathology of cases with known bone metastasis PIK3CA mutation status.

Case Bone metastasis Primary Time from Time from
PIK3CA
status
ER status PgR status HER2 status ER status PgR status HER2 status cancer diagnosis (years) metastatic cancer diagnosis (years)
2 E545K pos. pos. normal pos. pos. normal 11 11
3 WT pos. neg. normal pos. neg. normal 11 1
4 H1047R pos. neg. normal pos. pos. normal 14 2
11 WT pos. pos. normal pos. pos. normal 23 21
12 H1047R hom. pos.* neg.* amplified* pos. neg. amplified <1 <1
13 WT pos. neg. normal pos. pos. normal <1 <1

Estrogen (ER) and progesterone (PgR) statuses are shown as positive (pos.) or negative (neg.). Time from cancer diagnosis and metastatic cancer diagnosis is the time between diagnosis and the biopsy taken for this study. *determined from CT-guided bone biopsy; other metastasis receptor and HER2 data are determined from trephine biopsies.